EICHORCondition: Myocardial Infarction (MI) · Sponsor: Chonnam National University Hospital
This prospective, multicenter, open-label, superiority trial will enroll patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. Following successful percutaneous coronary intervention (PCI) of the infarct-related artery (IRA), patients who meet the eligibility criteria will be randomized in a 1:1 ratio to either in-hospital staged complete revascularization with PCI of non-IRA lesions performed on a separate day during hospitalization, at least 72 hours after PCI of the IRA, or out-of-hospital staged complete revascularization with PCI of non-IRA lesions performed after discharge between 15 and 45 days of randomization. In both groups, non-IRA lesions with 50-69% stenosis will be evaluated using FFR.
This description comes directly from the study's public registry record.
Min Chul Kim, MD, PhD · 82-10-4606-2643 · kmc3242@hanmail.net
Always discuss trial participation with your own doctor first.
| Bucheon Sejong Hospital | Bucheon-si, South Korea | — |
| Gyeongsang National University Changwon Hospital | Changwon, South Korea | — |
| Samsung Changwon Medical Center | Changwon, South Korea | — |
| Soon Chun Hyang University Hospital Cheonan | Cheonan, South Korea | — |
| Chungbuk National University Hospital | Cheongju-si, South Korea | — |
| Kangwon National University Hospital | Chuncheon, South Korea | — |
| Daegu Catholic University Medical Center | Daegu, South Korea | — |
| Keimyung University Dongsan Hospital | Daegu, South Korea | — |
| Kyungpook National University Hospital | Daegu, South Korea | — |
| Yeongnam University Medical Center | Daegu, South Korea | — |
| Chungnam National University Hospital | Daejeon, South Korea | — |
| Chonnam National University Hospital | Gwangju, South Korea | — |
+ 18 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07741721